Skip to main content
Clinical Trials/CTRI/2024/04/065755
CTRI/2024/04/065755
Not yet recruiting
Phase 3

Comparative Evaluation of Post-Operative Analgesic Efficacy of 15 ml of 0.375 % Ropivacaine versus 25 ml of 0.375 % Ropivacaine in patients undergoing hip fracture surgery under ultrasound guided Pericapsular Nerve Group Block: A Prospective Randomised Double Blinded Trial - NI

Aruna Bharti0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: S720- Fracture of head and neck of femurHealth Condition 2: S00-T88- Injury, poisoning and certain other consequences of external causes
Sponsor
Aruna Bharti
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Aruna Bharti

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient who had given written informed consent
  • 2\.Patients belonging to ASA grade I and II.
  • 3\.All genders
  • 4\.Patients in the age group of 18 yrs and above
  • 5\.Patient with hip fracture ( fracture neck of femur, intertrochanteric and subtrochanteric fractures).

Exclusion Criteria

  • 1\.Patient refusal.
  • 2\.ASA grade III and IV
  • 3\.Emergency surgeries
  • 4\.Patients with polytrauma
  • 5\.Patient who had allergy and intolerance to local anesthetics \& have active skin infection.
  • 6\.Patient with cognitive impairment, delirium, dementia and severe hearing impairment
  • 7\.Coexisting coagulopathy or anticoagulant or antiplatelet treatment that would be a contraindication to regional anesthesia.
  • 8\.Patient having diabetes, ischemic and valvular heart disease, pre\-existing neurologic deficits in the limb .

Outcomes

Primary Outcomes

Not specified

Similar Trials